| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.77B | +0.1% |
| R&D Expense | $307.0M | +13.3% |
| SG&A Expense | $1.48B | +6.4% |
| Operating Income | $207.0M | -37.1% |
| Interest Expense | $146.0M | — |
| Pre-tax Income | $73.0M | -77.0% |
| Income Tax | $58.0M | -53.6% |
| Net Income | $6.0M | -96.7% |
| EPS (Basic) | $0.02 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $354.0M | +103.4% |
| Accounts Receivable | $724.0M | +0.4% |
| Inventory | $628.0M | +9.8% |
| Current Assets | $2.14B | +30.7% |
| Total Assets | $11.14B | +3.0% |
| Current Liabilities | $1.30B | +17.9% |
| Long-term Debt | $2.41B | — |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $345.0M | -60.5% |
| Capital Expenditures | $175.0M | -9.3% |
| Investing Cash Flow | -$215.0M | -0.5% |
| Financing Cash Flow | $81.0M | +111.4% |
| Free Cash Flow | $170.0M | -75.0% |
| -96.2% |
| EPS (Diluted) | $0.02 | -96.2% |
| Total Liabilities |
| $4.04B |
| +184.5% |
| Stockholders' Equity | $7.03B | -24.6% |